Evaluation of the reproductive and developmental risks of caffeine

Wiley - Tập 92 Số 2 - Trang 152-187 - 2011
Robert L. Brent1, Mildred S. Christian2, Robert M. Diener3
1Thomas Jefferson University, Alfred I. duPont Hospital for Children, Wilmington, Delaware 19899, USA.
2Argus International, Inc., Horsham, Pennsylvania
3185 Aster Court, White House Station, New Jersey

Tóm tắt

AbstractA risk analysis of in utero caffeine exposure is presented utilizing epidemiological studies and animal studies dealing with congenital malformation, pregnancy loss, and weight reduction. These effects are of interest to teratologists, because animal studies are useful in their evaluation. Many of the epidemiology studies did not evaluate the impact of the “pregnancy signal,” which identifies healthy pregnancies and permits investigators to identify subjects with low pregnancy risks. The spontaneous abortion epidemiology studies were inconsistent and the majority did not consider the confounding introduced by not considering the pregnancy signal. The animal studies do not support the concept that caffeine is an abortafacient for the wide range of human caffeine exposures. Almost all the congenital malformation epidemiology studies were negative. Animal pharmacokinetic studies indicate that the teratogenic plasma level of caffeine has to reach or exceed 60 µg/ml, which is not attainable from ingesting large amounts of caffeine in foods and beverages. No epidemiological study described the “caffeine teratogenic syndrome.” Six of the 17 recent epidemiology studies dealing with the risk of caffeine and fetal weight reduction were negative. Seven of the positive studies had growth reductions that were clinically insignificant and none of the studies cited the animal literature. Analysis of caffeine's reproductive toxicity considers reproducibility and plausibility of clinical, epidemiological, and animal data. Moderate or even high amounts of beverages and foods containing caffeine do not increase the risks of congenital malformations, miscarriage or growth retardation. Pharmacokinetic studies markedly improve the ability to perform the risk analyses.Birth Defects Res (Part B)92:152–187, 2011. © 2011 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

Abenhaim L, 1991, Methodological issues for the assessment of clusters of adverse pregnancy outcomes in the workplace: the cause of video display terminal users, J Occup Med, 33, 1091

10.1016/0378-4274(80)90087-9

10.1203/00006450-200008000-00010

10.1177/153537020222700909

10.1073/pnas.87.19.7772

10.1016/j.fct.2004.11.011

10.1289/ehp.93101s233

10.1053/ejpn.2001.0497

10.3945/ajcn.2009.28792

Balat O, 2003, The effect of smoking and caffeine on the fetus and placenta in pregnancy, Clin Exp Obstet Gynecol, 30, 57

10.1016/S0002-9378(87)80301-0

10.1136/bmj.39062.520648.BE

Beckman DB, 1986, Clinics in perinatology, 615

Beckman DB, 1997, Handbook of human toxicology, 1007

Bernirschke K, 1974, Chromosomal errors and reproductive failure, Basic Life Sci, 73

Bertrand M, 1965, On the systematic and specific teratogenic effect of caffeine in rodents, C R Soc Biol, 159, 2199

Bertrand M, 1970, Ectrodactyly caused by caffeine in rodents. Role of specific and genetic factors, C R Seances Soc Biol Fil, 164, 1488

10.1007/s10654-006-9099-5

10.1016/j.tox.2007.08.092

Bodineau L, 2003, Consequences of in utero caffeine exposure on respiratory output in normoxic and hypoxic conditions and related changes of Fos expression: a study on brainstem‐spinal cord preparations isolated from newborn rats, Pediatr Res, 53, 266

10.1097/00004032-200307000-00013

Borlee I, 1978, Coffee, risk factor during pregnancy, Louvain Med, 97, 279

10.1002/tera.1420120103

10.2466/pms.2003.97.1.259

10.1017/S0007114508939842

10.1093/aje/kwf220

Brent RL, 1976, Prevention of embryonic, fetal and perinatal disease, 211

10.1002/tera.1420170212

Brent RL, 1985, Prevention of physical and mental congenital defects part c: basic and medical science, education and future strategies, 191

Brent RL, 1986, The law and congenital malformations, 615

Brent RL, 1986, Clinics in perinatology, 609

10.1002/tera.1420490302

10.1016/0890-6238(95)00020-B

Brent RL, 1995, Research monograph series 149: medications development for the treatment of pregnant addicts and their infants, 130

Brent RL, 1997, Modern scientific evidence: the law and science of expert testimony, 373

BrentRL.1999.The utilization of developmental basic science principles in the evaluation of reproductive risks from pre‐ and postconception environmental radiation exposures. Teratology 59:182–204. Paper presented at the Thirty‐Third Annual Meeting of the National Council on Radiation Protection and Measurements The Effects of Pre‐ and Postconception Exposure to Radiation April 2–3 1997 Arlington Virginia.

10.1002/bdra.10021

Brent RL, 2004, Pediatric supplement: vulnerability, sensitivity and resiliency of infants, 357

10.1002/bdra.20184

10.1097/01.HP.0000282111.66056.c2

Brent RL, 2008, Progress in obstetrics and gynecology 18, 61

Brent RL, 1986, Radiation risks to the developing nervous system, 367

Brent RL, 1990, Environmental teratogens, Bull N Y Acad Med, 66, 123

10.1002/tera.1420380308

10.1097/01.ede.0000208476.36988.44

10.1002/bdra.20365

10.1191/0960327102ht224oa

10.1016/S0890-6238(02)00097-7

10.1191/0960327104ht439oa

Burdan F, 2000, The effects of short‐time caffeine administration on skeleton development in Wistar rats, Folia Morphol (Warsz), 59, 91

10.1191/096032701718620873

10.1007/978-94-009-5816-6_1

Butcher RW, 1962, Adenosine 3′,5′‐phosphate in biological materials. I. Purification and properties of cyclic 3′,5′nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3′,5‐phosphate in human urine, J Biol Chem, 237, 1244

10.1097/00008571-199608000-00002

10.1002/bdrb.10048

10.1002/(SICI)1096-9926(199904)59:4<210::AID-TERA4>3.0.CO;2-X

10.1136/bmj.a2332

10.1002/bdra.20533

Chorostowska‐Wynimko J, 2004, Multiple effects of theobromine on fetus development and postnatal status of the immune system, Int J Tissue React, 26, 53

10.1002/tera.1047

10.1093/aje/155.5.429

10.1203/PDR.0b013e3180a725b1

10.1056/NEJM200012213432503

10.1002/bdra.20600

CollinsTFX WelshJJ BlackTN RugglesDI. 1981.Teratogenic potential of caffeine in rats. In: Alternative dietary practices and nutritional abuses in pregnancy. Proceedings of a Workshop. Washington DC: National Academy Press. p 97–107.

10.1016/0278-6915(83)90211-9

10.1016/0031-9384(95)00140-E

10.1046/j.1525-1373.1999.d01-17.x

10.1002/tera.1025

Committee on Toxicity.2001. COT statement on the reproductive effects of caffeine. London: Committee on Toxicity of Chemicals in Food Consumer Products and the Environment 2001 http://cot.food.gov.uk/cotstatements/cotstatementsyrs/cotsatemnt0s2001/caffeine

10.1136/bmj.313.7069.1358

10.1016/j.ejphar.2005.01.001

10.1016/j.ijdevneu.2007.12.006

10.1097/01.fpc.0000167326.00411.50

10.1203/PDR.0b013e318156e425

10.1300/J029v17n02_03

10.1093/oxfordjournals.epirev.a036093

10.1097/00007691-199912000-00003

10.1016/0300-483X(82)90041-5

Evereklioglu C, 2003, High dose caffeine administered to pregnant rats causes histopathological changes in the cornea of newborn pups, Med Sci Monit, 9, BR168

10.1111/j.1600-0420.2004.00331.x

10.1177/003591577406700513

10.2105/AJPH.81.4.458

10.1093/oxfordjournals.aje.a009477

Food and Drug Administration (FDA), 1980, Caffeine and pregnancy, FDA Drug Bull, 10, 19

Food and Drug Administration (FDA).1986. See Johnson CB Shibko SI Taylor JM.Caffeine. Review of toxicological studies 1980‐present (September 1986) FDA Review.

10.1016/S0278-6915(98)00021-0

10.1016/0041-008X(72)90252-9

10.1016/j.autneu.2006.03.009

10.1111/j.1365-3016.2006.00703.x

10.1046/j.1365-3016.2003.00523.x

10.1002/1096-8628(20000731)93:3<253::AID-AJMG19>3.0.CO;2-Z

10.1530/jrf.0.0340495

10.1016/0272-0590(91)90197-C

10.1006/faat.1994.1006

Gilbert SG, 1988, Adverse pregnancy outcome in the monkey (Macaca fasicularis) after chronic caffeine exposure, Pharmacol Exp Therap, 245, 1048

10.1007/s10654-010-9443-7

Gregg NM, 1941, Congenital cataract following German measles in he mother, Trans Ophthalmol Soc Aust, 3, 35

10.1097/00001648-200107000-00015

10.1093/aje/kwj125

Heinonen OP, 1977, Birth defects and drugs in pregnancy, 11, 366

10.1007/978-3-642-48949-5_2

10.1093/jn/130.2.152

10.1007/s00726-005-0293-7

10.1111/j.1365-3016.2007.00825.x

10.1002/jat.2550020609

James JE, 1985, Caffeine and human reproduction, Rev Environ Health, 5, 151

10.1053/rvsc.2000.0381

10.1053/rvsc.2000.0446

10.1093/aje/kwp040

10.1016/S0300-483X(99)00211-5

10.1007/BF00329132

10.1016/j.fertnstert.2006.03.059

10.1196/annals.1389.012

10.3109/15563658408992578

10.1080/14767050310001650716

10.1016/S1047-2797(97)00125-7

10.1056/NEJM199911253412202

10.1093/aje/155.1.32

Kline J, 1985, Environmental causes of aneuploidy: why so elusive?, Basic Sci, 36, 149

Kline J, 1980, Human embryonic and fetal death

10.1093/humrep/17.7.1746

Knoche C, 1964, Zur pranatalen toxiziat von diphenylpyralin‐8‐chlortheophyllinat unterberuck‐sichtgung von erfahrungen mit thalidomide und cafffein, Arzeimittelforschung, 14, 415

10.1016/S0940-2993(99)80019-0

10.1016/0002-9378(70)90484-9

10.2105/AJPH.73.12.1397

10.1016/S0006-2952(02)01019-5

10.1016/j.reprotox.2004.03.004

10.1046/j.1471-4159.2002.01008.x

10.1016/j.neuroscience.2004.11.028

10.1111/j.1471-4159.2005.03211.x

Leuschner F, 1969, Caffein und anderemethylxanthine, 209

10.1016/S0278-6915(02)00092-3

10.1097/00001648-200201000-00004

10.1056/NEJM198201213060304

Londos C, 1981, Receptor‐mediated stimulation and inhibition of adenylate cyclases: the fat cell as a model system, Adv Cyclic Nucleotide Res, 14, 163

10.1016/S0378-4320(99)00084-6

10.1111/j.1365-3016.2006.00723.x

10.1002/1096-9926(200011)62:5<325::AID-TERA6>3.0.CO;2-H

10.1111/j.1471-0528.2006.01193.x

10.1093/oxfordjournals.aje.a114718

10.1203/00006450-199312000-00004

10.1002/ajmg.1320280548

Mau G, 1974, Kaffee und alkoholkonsum,risikofaktoren in der schwangerschaft, Geburtsh Frauenheilkd, 34, 1018

10.1007/BF03190376

10.1055/s-2007-994095

Mead PB, 1989, Parvovirus B19 infection and pregnancy, Contemp Ob Gyn, 34, 56

10.1111/j.1365-3016.2008.00976.x

10.1152/ajpheart.91469.2007

10.1262/jrd.49.507

10.1093/aje/kwm311

10.1016/S0140-6736(87)91012-9

10.1016/0024-3205(86)90653-3

Nash JE, 1988, Reproductive and teratologic riska of caffeine, Anat Anz Jena, 167, 265

10.1054/bjom.1999.0133

10.1080/0265203021000007840

10.1002/(SICI)1096-9926(199904)59:4<216::AID-TERA5>3.0.CO;2-O

10.1146/annurev.ge.24.120190.001551

10.1080/07315724.1994.10718366

10.1136/bmj.1.5748.523

10.3181/00379727-104-25757

10.1016/0041-008X(81)90421-X

Nolen GA, 1989, Issues and reviews in teratology, 305

10.1016/j.jnutbio.2003.12.007

10.1002/mpo.2950190603

10.1111/j.1651-2227.1991.tb11812.x

10.1093/ije/13.3.347

10.1097/00001648-199109000-00011

10.1016/S0029-7844(03)00402-2

10.1016/0041-008X(78)90279-X

10.1038/sj.ejcn.1602052

10.1136/jech.45.2.159

Peck K, 1997, Comparative pharmacokinetics of caffeine and three metabolites in clinically normal horses and donkeys, Am J Vet Res, 58, 881, 10.2460/ajvr.1997.58.08.881

10.1016/j.fct.2010.06.019

10.1007/s00210-001-0527-5

10.1016/0301-0082(81)90014-9

Pieters JJL, 1985, Nutritional teratogens: a survey of epidemiology literature, Prog Clin Biol Res, 163, 419

10.1080/15287398709531046

10.1071/RD01018

Purves D, 1993, Monographs of the Mario Negri Institute for pharmacological research, 317

Rall DP, 1980, Carcinogenicity testing of drugs, JAMA, 243, 1035, 10.1001/jama.1980.03300360011005

10.1034/j.1600-0412.2003.00078.x

10.1016/0892-0362(90)90004-V

Rosenberg L, 1982, Selected birth defects in relation to caffeine‐containing beverages, JAMA, 247, 1429, 10.1001/jama.1982.03320350033024

10.1016/j.neuroscience.2004.05.006

10.1016/S0165-3806(00)00037-7

10.1093/cercor/11.4.343

10.1016/j.tox.2007.08.092

Santos IS, 2005, Mate drinking during pregnancy and risk of preterm and small for gestational age birth, J Nutr, 135, 1120, 10.1093/jn/135.5.1120

10.1093/molehr/gah175

Sattin A, 1970, The effect of adenosine and adenine nucleotides on the cyclic adenosine 3′,5′‐phosphate content of guinea pig cerebral cortex slices, Mol Pharmacol, 6, 13

10.1093/aje/kwn193

10.3109/9780203909904

10.1002/bdra.20624

10.1016/S0378-4347(99)00040-7

Scialli AR, 1995, Reproductive effects of chemical, physical, and biological agents

Shepard TH, 1986, Advances in pediatrics, 225

10.1002/tera.1420500202

10.1007/BF00733753

10.1097/01.ede.0000112221.24237.0c

10.1016/S0029-7844(01)01575-7

10.1016/S0015-0282(16)44528-0

10.1006/rtph.1994.1001

10.1093/aje/kwn248

10.1016/S0022-3476(47)80158-1

10.1016/0278-6915(87)90145-1

10.1056/NEJM198407263110410

10.1016/0278-6915(88)90236-0

10.1016/0278-6915(92)90106-U

10.1093/oxfordjournals.aje.a112163

10.1016/0306-4522(81)90145-7

Sullivan FM, 1987, Pharmacokinetics in teatogenesis, 123

10.1093/oxfordjournals.aje.a113542

Sutherland EW, 1958, Fractionation and characterization of a cyclic adenine ribonucleoide formed by tissue particles, J Biol Chem, 232, 1077, 10.1016/S0021-9258(19)77423-7

10.1016/S0387-7604(83)80045-X

10.1016/S0093-691X(02)01124-X

10.1046/j.1365-2885.1999.00226.x

10.1093/humrep/deg480

10.1177/1933719107307717

10.1093/aje/152.12.1185

10.1016/j.ijgo.2005.09.011

10.1111/j.1471-4159.1979.tb05236.x

10.1046/j.1365-3016.2003.00507.x

10.1093/oxfordjournals.aje.a009110

10.1007/978-3-642-69823-1_10

10.1053/rvsc.2000.0389

10.1111/j.1471-0528.1989.tb03229.x

10.1097/00001648-200101000-00008

10.1016/j.ajog.2007.10.803

10.1016/S0002-9378(15)33279-8

10.1086/421473

World Health Organization.1970.Spontaneous and induced abortion. World Health Organization Technical Report Series Number 461 Geneva World Health Organization.

10.1093/humrep/dem316

10.1093/molehr/6.5.474